Consolidated Statement of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
Research and development	$ 15,489,997	$ 23,115,123
General and administrative	7,431,108	7,834,155
Operating loss	(22,921,105)	(30,949,278)
Other income (expense), net:
Interest Income (Expense), Net	463,256	253,323
Other income (loss), net	(10)	2,704,743
Net loss	$ (22,457,859)	$ (27,991,212)
Per common share data:
Basic net loss per common share	$ (0.65)	$ (0.83)
Diluted net loss per common share	$ (0.65)	$ (0.83)
Weighted average number of common shares outstanding, basic	34,359,945	33,672,927
Weighted average number of common shares outstanding, diluted	34,359,945	33,672,927
Other comprehensive gain (loss)
Foreign currency translation gain (loss)	$ (138,479)	$ 332,801
Comprehensive loss	$ (22,596,338)	$ (27,658,411)